Product Pathways - Chromatin Regulation

HP1α Blocking Peptide #1004

• pathway
• more info
• application references
• datasheet PDF
• MSDS PDF

Description

This peptide is used to block HP1α Antibody #2616 and HP1α (C7F11) Rabbit mAb #2623 reactivity in immunohistochemistry protocols.

Quality Control

The quality of the peptide was evaluated by reversed-phase HPLC and by mass spectrometry. The peptide blocks HP1α Antibody #2616 and HP1α (C7F11) Rabbit mAb #2623 by immunohistochemistry.

Applications

Directions for Use

For immunohistochemistry, add twice the volume of peptide as volume of antibody used in 100 µl total volume. Incubate for a minimum of 30 minutes prior to adding the entire volume to the slide. Recommended antibody dilutions can be found on the relevant product data sheet.

Background

Heterochromatin protein 1 (HP1) is a family of heterochromatic adaptor molecules involved in both gene silencing and higher order chromatin structure (1). All three HP1 family members (α, β and γ) are primarily associated with centromeric heterochromatin; however, HP1β and γ also localize to euchromatic sites in the genome (2,3). HP1 proteins are approximately 25 kDa in size and each contains a conserved amino-terminal chromodomain, followed by a variable hinge region and a conserved carboxy-terminal chromoshadow domain. The chromodomain facilitates binding to histone H3 tri-methylated on Lys9, a histone "mark" closely associated with centromeric heterochromatin (4,5). The variable hinge region binds both RNA and DNA in a sequence-independent manner (6). The chromoshadow domain mediates the dimerization of HP1 proteins, in addition to binding multiple proteins implicated in gene silencing and heterochromatin formation, including the SUV39H histone methyltransferase, the DNMT1 and DNMT3a DNA methyltransferases and the p150 subunit of chromatin-assembly factor-1 (CAF1) (7-9). In addition to contributing to heterochromatin formation and propagation, HP1 and SUV39H are also found complexed with retinoblastoma (Rb) and E2F6 proteins, both of which function to repress euchromatic gene transcription in quiescent cells (10,11). HP1 proteins are subject to multiple types of post-translational modifications, including phosphorylation, acetylation, methylation, ubiquitination and sumoylation, suggesting multiple means of regulation (12-14).

1. Maison, C. and Almouzni, G. (2004) Nat. Rev. Mol. Cell Biol. 5, 296-304.
2. Minc, E. et al. (2000) Cytogenet. Cell Genet. 90, 279-284.
3. Nielsen, A.L. et al. (2001) Mol. Cell 7, 729-739.
4. Lachner, M. et al. (2001) Nature 410, 116-120.
5. Bannister, A.J. et al. (2001) Nature 410, 120-124.
6. Muchardt, C. et al. (2002) EMBO Rep. 3, 975-981.
7. Yamamoto, K. and Sonoda, M. (2003) Biochem. Biophys. Res. Commun. 301, 287-292.
8. Fuks, F. et al. (2003) Nucleic Acids Res. 31, 2305-2312.
9. Murzina, N. et al. (1999) Mol. Cell 4, 529-540.
10. Nielsen, S.J. et al. (2001) Nature 412, 561-565.
11. Ogawa, H. et al. (2002) Science 296, 1132-1136.
12. Minc, E. et al. (1999) Chromosoma 108, 220-234.
13. Zhao, T. et al. (2001) J. Biol. Chem. 276, 9512-9518.
14. Lomberk, G. et al. (2006) Nat. Cell Biol. 8, 407-415.

Application References

Have you published research involving the use of our products? If so we'd love to hear about it. Please let us know!

Companion Products

• 2616 HP1α Antibody
• 2623 HP1α (C7F11) Rabbit mAb

This product is for in vitro research use only and is not intended for use in humans or animals. This product is not intended for use as therapeutic or in diagnostic procedures.